G

Global Health Ltd
NSE:MEDANTA

Watchlist Manager
Global Health Ltd
NSE:MEDANTA
Watchlist
Price: 1 234 INR 0.18% Market Closed
Market Cap: ₹332B

Wall St Price Targets

MEDANTA Price Targets Summary
Global Health Ltd

Wall Street analysts forecast MEDANTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDANTA is 1 309.99 INR with a low forecast of 1 131.2 INR and a high forecast of 1 522.5 INR.

Lowest Forecast
Price Target
1 131.2 INR
8% Downside
Average Forecast
Price Target
1 309.99 INR
6% Upside
Highest Forecast
Price Target
1 522.5 INR
23% Upside
Global Health Ltd Competitors:
Price Targets
HURN
Huron Consulting Group Inc
91% Upside
FILA
FILA Fabbrica Italiana Lapis ed Affini SpA
58% Upside

Revenue
Forecast

26% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
26% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 4 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 4 years is 17%.

Gross Profit
Forecast

27% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
27% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Global Health Ltd

Operating Income
Forecast

76% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
76% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 4 years, the compound annual growth rate for Operating Income has been 76%. The projected CAGR for the next 4 years is 17%.

Pre-Tax Income
Forecast

111% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
111% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Global Health Ltd

Net Income
Forecast

102% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
102% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 4 years, the compound annual growth rate for Net Income has been 102%. The projected CAGR for the next 4 years is 21%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MEDANTA's stock price target?
Price Target
1 309.99 INR

According to Wall Street analysts, the average 1-year price target for MEDANTA is 1 309.99 INR with a low forecast of 1 131.2 INR and a high forecast of 1 522.5 INR.

What is the Revenue forecast for Global Health Ltd?
Projected CAGR
17%

Over the last 4 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 4 years is 17%.

What is the Operating Income forecast for Global Health Ltd?
Projected CAGR
17%

Over the last 4 years, the compound annual growth rate for Operating Income has been 76%. The projected CAGR for the next 4 years is 17%.

What is the Net Income forecast for Global Health Ltd?
Projected CAGR
21%

Over the last 4 years, the compound annual growth rate for Net Income has been 102%. The projected CAGR for the next 4 years is 21%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett